Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia

NCT01515020 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped lack of inclusion

Conditions

Nosocomial Infection
Healthcare-associated Infection

Interventions

DRUG: vancomycin monotherapy
DRUG: daptomycin monotherapy

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]